Cell capable of producing adeno-associated virus vector
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 23, 2016
Grant Date -
Oct 15, 2015
app pub date -
Jun 26, 2013
filing date -
Jul 6, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
According to the present invention, an AAV vector having a higher titer compared with those of conventional ones can be produced using a cell into which a nucleic acid capable of expressing miRNA is introduced artificially. An AAV vector produced using the cell and a composition containing the viral vector as an active ingredient are very useful as gene transfer means in the studies or clinical practice of gene therapies.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully